Aptamer Group PLC Results of 2023 Annual General Meeting (0395X)
December 15 2023 - 9:57AM
UK Regulatory
TIDMAPTA
RNS Number : 0395X
Aptamer Group PLC
15 December 2023
15 December 2023
Aptamer Group plc
("Aptamer", the "Company" or the "Group")
Results of 2023 Annual General Meeting
Aptamer Group plc (AIM: APTA), the developer of novel Optimer(R)
binders to enable innovation in the life sciences industry, today
announces that the results of voting on the resolutions put to
shareholders at its Annual General Meeting ("AGM") held earlier
today at 10:00 GMT at the offices of Aptamer Group, Windmill House,
Innovation Way, York, YO23 1LR, all Resolutions were duly passed.
Further details of each of the resolutions are set out in the
Notice of Meeting, which was sent to shareholders on 20 November
and the full poll results will be made available on the Aptamer
website later today.
- ENDS -
For further information, please contact:
Aptamer Group plc
Steve Hull +44 (0) 1904 217 404
SPARK Advisory Partners Limited - Nominated
Adviser
Andrew Emmott / Mark Brady / Adam Dawes +44 (0) 20 3368 3550
-----------------------
T urner Pope I nvestments (TPI) Limited
- B roker
J ames Pope / Andrew Thacker +44 (0) 20 36 57 0 050
-----------------------
About Aptamer Group plc
Aptamer Group develops custom affinity binders through its
proprietary Optimer (R) platform to enable new approaches in
therapeutics, diagnostics, and research applications. The Company
strives to deliver transformational solutions that meet the needs
of life science researchers and developers.
Optimer binders are oligonucleotide affinity ligands that can
function as an antibody alternative. The global affinity ligand
market is currently worth over $170 billion.
Aptamer has successfully delivered projects for a range of
global pharma companies, diagnostic development companies, and
research institutes, covering multiple application areas with the
objective of establishing royalty-bearing licenses.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGEELFFXLLEFBE
(END) Dow Jones Newswires
December 15, 2023 10:57 ET (15:57 GMT)
Aptamer (LSE:APTA)
Historical Stock Chart
From Apr 2024 to May 2024
Aptamer (LSE:APTA)
Historical Stock Chart
From May 2023 to May 2024